Haloperidol as a treatment option in cannabinoid hyperemesis syndrome.

Prz Gastroenterol

Miller School of Medicine Palm Beach Regional Campus, University of Miami, Miami, United States.

Published: December 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743336PMC
http://dx.doi.org/10.5114/pg.2022.121826DOI Listing

Publication Analysis

Top Keywords

haloperidol treatment
4
treatment option
4
option cannabinoid
4
cannabinoid hyperemesis
4
hyperemesis syndrome
4
haloperidol
1
option
1
cannabinoid
1
hyperemesis
1
syndrome
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!